Princeton Global Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Princeton Global Asset Management’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-116	Closed	–	–	599
2022 Q3	$0	Hold	116	–	–	﹤0.01%	579
2022 Q2	$0	Hold	116	–	–	﹤0.01%	611
2022 Q1	$0	Hold	116	–	–	﹤0.01%	615
2021 Q4	$1K	Hold	116	–	–	﹤0.01%	517
2021 Q3	$1K	Hold	116	–	–	﹤0.01%	507
2021 Q2	$1K	Hold	116	–	–	﹤0.01%	531
2021 Q1	$1K	Hold	116	–	–	﹤0.01%	488
2020 Q4	$1K	Hold	116	–	–	﹤0.01%	477
2020 Q3	$1K	Hold	116	–	–	﹤0.01%	440
2020 Q2	$0	Buy	+116	New	+$444	﹤0.01%	571

Other funds holding SRNE

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Princeton Global Asset Management's SRNE Position: Q4 2022 in Review

Princeton Global Asset Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2022, closing a stake of 116 shares.

Princeton Global Asset Management first reported a position in SRNE in Q2 2020 and held it in 10 quarters. The position peaked at $1K in Q4 2021. 221 funds tracked by Wall St. Rank hold SRNE as of Q4 2022.

Princeton Global Asset Management reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Princeton Global Asset Management sold 116 Sorrento Therapeutics, Inc. shares in Q4 2022.
Princeton Global Asset Management first reported a position in Sorrento Therapeutics, Inc. in Q2 2020 and held it in 10 quarters.
Princeton Global Asset Management's Sorrento Therapeutics, Inc. position peaked at $1K in Q4 2021.
221 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2022.

Based on Princeton Global Asset Management's 13F filing for Q4 2022, filed 6 Feb 2023.